Biotypes of Candida albicans Isolated from Cardiovascular System and Skin Surveillance Cultures of Hospitalized Patients by Verica Verica Važić-Babić et al.
219
Acta Dermatovenerol Croat          2006;14(4):219-224        ORIGINAL SCIENTIFIC ARTICLE
Biotypes of Candida albicans Isolated from 
Cardiovascular System and Skin Surveillance Cultures 
of Hospitalized Patients
Verica Važić-Babić1, Emilija Mlinarić-Missoni1, Smilja Kalenić2 
1Mycology Department, Croatian National Institute of Public Health, Zagreb, Croatia
2Department of  Clinical and Molecular Microbiology, Zagreb University Hospital 




Croatian National Institute of  Public Health
Rockefellerova 2
HR-10000 Zagreb,  
Croatia
verica.vazic.babic@hzjz.hr
Received: July 14, 2006
Accepted: September 13, 2006
SUMMARY The aim of the study was to biotype 59 isolates of 
Candida (C.) albicans from cardiovascular system samples 
(blood and intravenous catheter) and 123 isolates of the same 
species from skin surveillance cultures (swabs of the armpit, 
groins and intravenous catheter insertion sites) of hospitalized 
patients using the Odds and Abbott biotyping method. Biotyping 
of 59 isolates of C. albicans taken from the cardiovascular system 
samples revealed the presence of 16 biotypes. Biotype 355 was 
the most common biotype, accounting for 35.6% of all biotype 
isolates from this system. Biotyping of 123 C. albicans isolates 
from skin surveillance cultures detected 21 biotypes. Biotype 
355 was most common, accounting for 17.9% of all biotype 
isolates from these samples. The two systems had 10 biotypes 
in common: 355, 155, 257, 305, 105, 315, 300, 015, 157, and 
345. These biotypes accounted for 88.3% and 81.4% of all C. 
albicans biotypes isolated from the cardiovascular system and 
skin surveillance cultures, respectively. Biotypes 355, 155, and 
257 were the biotypes most frequently shared in isolates from the 
two systems. These biotypes accounted for 57.7% and 43.1% of 
all C. albicans biotypes isolated from the cardiovascular system 
and skin surveillance cultures, respectively. 
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INTRODUCTION
 Candida (C.) albicans is ubiquitous commensal 
yeast in humans in whom it is part of the physio-
logical ﬂora of the skin and mucous membranes. In 
individuals with preserved immunity, it may cause 
disease exceptionally rarely. When body defenses 
fail for any reason, this yeast behaves opportu-
nistically. As the number of immunocompromised 
patients across the world is steadily increasing, 
the incidence of fungal infections follows this trend 
(1,2). Candida spp. are the most common agents 
(78.3%) of fungal nosocomial infections, and C. al-
bicans has been demonstrated to be the causative 
agent in more than 50% of these infections (3-5).
 The ever greater use of intravenous catheters 
is the reason for this increase in the incidence of 
fungemia coupled with the use of catheter in im-
munocompromised patients. This is due to the 
220 ACTA DERMATOVENEROLOGICA CROATICA
opportunistic species of the fungus from the pa-
tient’s skin and his surrounding (6,7). In 50% to 
80% of candidemia in patients with hematologic 
malignancies, intravenous catheter is the site of 
Candida introduction into the bloodstream (8). 
In these patients candidemia may result in the 
development of severe and often fatal invasive 
and disseminated candidiasis (endocarditis, en-
dophthalmitis, microabscesses in the brain and 
kidney, etc.) (5,9). In some 50% of immunocom-
promised patients, C. albicans is isolated from the 
skin around the catheter insertion site. In addition 
to the source of yeast from the patient’s own skin, 
yeasts from the patient’s environment (e.g., con-
taminated objects and infusion solutions as well 
as the hands of hospital staff and secretions from 
their respiratory systems) may also lead to coloni-
zation of intravenous catheter. This may also oc-
cur secondarily by hematogenous dissemination 
of the yeast from a remote focus of inﬂammation 
with the same yeast (6,8,10,11).
 A variety of phenotyping (biotyping, serotyp-
ing, morphotyping, enzyme typing, assessment of 
sensitivity to antimycotics and “killer” toxins, etc.) 
and genotyping methods have been employed to 
identify the types of C. albicans (12,13). Results 
reported by other workers have pointed to the bio-
typing method as being highly reproducible and 
able to differentiate particular types within the C. 
albicans species (13). 
 The aim of the present study was to identify the 
types of C. albicans isolates taken from samples 
of the cardiovascular system and skin surveillance 
cultures of inpatients using the Odds and Abbott 
biotyping method (14,15). This typing method al-
lows for identiﬁcation of 512 different biotypes of 
this species, which enables monitoring of the fre-
quency of individual biotypes in different systems 
of the patient as well as detection of the poten-
tial sources of infection. The method is suitable 
to examine a large number of isolates and does 




 Fifty-nine isolates of C. albicans from the car-
diovascular system (blood and intravenous cath-
eter) and 123 C. albicans isolates from skin sur-
veillance cultures (swabs of armpit, groins and 
intravenous catheter insertion sites) were typed. 
The samples derived from patients hospitalized at 
Sterile Unit, Department of Hematology, Univer-
sity Department of Medicine, Zagreb University 
Hospital Center. 
Isolation and identiﬁcation methods
 All clinical material samples were inoculated 
onto Sabouraud’s glucose agar and incubated 
aerobically at 37 ºC for 3 to 7 days. Identiﬁcation 
of C. albicans was made by standard tests (test 
of germination, assimilation and sugar fermenta-
tion tests, and development of chlamydospores on 
cornmeal agar) and commercial tests (ID 32 C and 
API 20 C AUX, BioMerieux) (3,16). 
Biotyping method
 The isolates were stored at -26 ºC in glycerin 
broth until analysis. Resuscitated isolates were 
typed by using the Odds and Abbott method 
(14,15). Each isolate underwent testing on nine 
different media (those to examine its tolerance of 
pH 1.4 and increased NaCl concentrations, thus 
testing its ability to excrete proteinase and assimi-
late urea, citrates and sorbose, and its resistance 
to 5-ﬂuorocytosine, boric acid and safranin). The 
isolate growth on a given medium was considered 
as positive test outcome; the same person read 
all test media (Figs. 1-4). Test media were divided 
into three groups, the biotype of each isolate being 
marked with a 3-digit number accordingly. Each 
digit was calculated based on the sum of test re-
sults within each group.  
RESULTS
 Table 1 illustrates the frequency of C. albicans 
biotypes isolated from cardiovascular system. 
Sixteen biotypes were typed in 59 isolates. The 
a) b)
Figure 1. (a) Multiple inoculator for preparing sus-
pension of Candida albicans isolates; (b) multiple 
inoculator for inoculating Candida albicans iso-
lates onto different media.
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four most common biotypes (355, 155, 257 and 
305) accounted for 66.2% and the remaining 12 
biotypes for 33.8% of all biotypes from the cardio-
vascular system samples. The prevalence of bio-
type 355 was highest with 35.6% of all biotypes. 
Biotype 155 had a prevalence of 13.6%, and bio-
types 257 and 305 of 8.5% each (Fig. 5). 
 The frequency of C. albicans biotypes isolated 
from skin surveillance cultures (armpit, groin and 
catheter insertion site swabs) is shown in Table 
2. Typing of 123 isolates yielded 21 biotypes. The 
four most common biotypes (355, 155, 257 and 
300) accounted for 53.7% of all biotypes from skin 
surveillance cultures. Biotype 355 was most prev-
alent (17.9%), followed by biotypes 155 (13.0%), 
257 (12.2%) and 300 (10.6%) (Fig. 6). 
 Table 3 presents biotypes of C. albicans isolates 
taken from samples of the cardiovascular system 
and skin surveillance cultures of 16 hematologi-
cal patients. Isolates taken from these samples of 
each individual patient belonged to one to three 
biotypes. In 14 (87.5%) patients, the biotypes 
found in the isolates from cardiovascular system 
and skin surveillance cultures were the same.
Table 1. Frequency of Candida albicans biotypes 
isolated from cardiovascular system 
Biotype No. of isolates (%)
355 21 (35.6)
155 8 (13.6)
257, 305 10 (17.0)
105 4 (6.8)
315, 300 6 (10.2)
017 2 (3.4)
015, 045, 100, 115, 
157, 314, 345, 360 8 (13.6)
Total  16 59 (100)
Figure 3. Growth of 40 Candida albicans isolates 
on glycine medium to demonstrate its ability to use 
glycine as the source of nitrogen and carbon. 
Table 2.  Frequency of Candida albicans biotypes 
isolated from skin surveillance cultures 






305, 345 16 (13.0)
144, 157, 241, 315, 357 20 (16.5)
041 3 (2.4)
147 2 (1.5)
005, 015, 055, 175, 205, 
325, 755 7 (5.6)
Total 21 123 (100)
DISCUSSION 
 C. albicans isolates typed in the present study 
originated from samples of the cardiovascular 
system (blood and intravenous catheter) and of 
the skin surveillance cultures (armpit, groin, and/
or catheter insertion site swabs) from hospital-
ized hematological patients. Intravenous catheter 
was the site of Candida spp. introduction in the 
bloodstream in 50% to 80% of candidemia, and C. 
albicans was responsible for 55% of these infec-
tions (2,5,6,8,10). In about 50% of immunocom-
promised patients, C. albicans was isolated from 
the skin around the intravenous catheter insertion 
site (6,7,10,11). 
 These data have prompted us to attempt typ-
ing and comparing the detected types of C. albi-
cans isolated from the cardiovascular system and 
surveillance skin cultures of hospitalized hemato-
Figure 2. Growth of 49 Candida albicans isolates 
on control medium.
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logical patients. The Odds and Abbott biotyping 
method was chosen for typing for its simple per-
formance and allowing for examination of a large 
number of samples without entailing great mate-
rial expenses or expensive equipment. Although 
the methods of genotyping are currently also 
available for microorganism (and yeast) typing, 
phenotyping methods are still in common use in 
epidemiological studies of nosocomial infections 
(17).  Literature reports of research ﬁndings on the 
biotyping of C. albicans isolates with the Odds and 
Abbott method are very scarce. Most research-
ers typed isolates of this species originating from 
two systems, genitourinary and digestive systems 
(14,18). Although this method permits typing of 
512 different C. albicans biotypes, the reported 
typing results have revealed much fewer (from 25 
to 79) biotypes (14,18).
 On typing C. albicans isolates taken from skin 
surveillance cultures of hematological inpatients, 
the present study found a greater number of bio-
types (n=21) in these than in the cardiovascular 
system samples from the same patients (n=16). In 
the isolates from these samples, 10 biotypes were 
the same: their frequency in the isolates from sam-
ples of the cardiovascular system and skin surveil-
lance cultures was 88.3% and 81.4%, respective-
ly. The present study demonstrated a high coinci-
dence (87.5%) between the biotypes recorded in 
isolates from the cardiovascular system samples 
Table 3.  Biotypes of Candida albicans isolated from cardiovascular system samples (blood and/or intra-
venous catheter) and skin surveillance cultures (swabs of armpit, groin and/or site of catheterization) in 
16 hospitalized hematological patients
Patient
Cardiovascular system Skin surveillance cultures
Blood Intravenous catheter Catheterization site   Armpit/groin
1 355 355
2 155 155 155
3 315 300 305
4 355 355 355
5 357 355 357
6 357 357
7 155 155
8 157 257 157,257
9 155 157 155, 157
10 355 315 315
11 257 257
12 300 300
13 345 345 345
14 305 315
15 105 105 105
16 157 157
Figure 4. Growth of 43 Candida albicans isolates 










Figure 5. Prevalence of the four most common 
Candida albicans biotypes isolated from the car-
diovascular system. 
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and skin surveillance cultures in 16 hematological 
inpatients. Klempp-Selb et al. obtained compara-
ble results. They typed chromosomal DNA of 19 
C. albicans isolates taken from blood samples and 
36 C. albicans isolates taken from other samples 
(stool, urine, sputum, vaginal swabs, and swabs of 
the skin around the site of central venous catheter 
insertion) from six hospitalized patients.  Karyo-
typing revealed the presence of 10 different karyo-
types. In 5 (83.3%) patients, the karyotypes in the 
isolates from blood and other samples proved to 
be the same (19). Using the “killer-yeasts” typing 
method, Candido et al. typed 146 C. albicans iso-
lates taken from various samples of hospitalized 
patients, i.e. blood, stool, bronchoalveolar lavage, 
urine, swabs of the oral cavity, vagina, skin lesions 
and intact skin). Typing detected 23 biotypes, the 
most common being 211, 111 and 811. Type 211 
was most common among the isolates from blood 
samples (20). Betremieux et al. typed C. albicans 
isolates obtained from blood samples of seven 
premature infants admitted to intensive care unit 
(ICU), and C. albicans isolates from swabs of the 
skin of hospital staff hands. Five methods (se-
rotyping, morphotyping, resistance typing, “kill-
er-yeast” typing, and genotyping) were used on 
typing. All blood sample isolates were of the same 
type as the isolate from the skin of the hand of an 
ICU worker, indicating the role of yeasts from the 
patient’s surrounding in intrahospital candidemia 
(21).  
CONCLUSION
 Biotyping of 59 C. albicans isolates obtained 
from the cardiovascular system of hospitalized he-
matological patients showed 16 biotypes. Biotyp-
ing of 123 C. albicans isolates from surveillance 
cultures of the skin of the same patients revealed 
21 biotypes. Three most common biotypes (355, 
155 and 257) accounted for 57.7% of all C. albi-
cans biotypes isolated from the cardiovascular 
system and 43.1% of all biotypes of the C. albicans 
isolates from surveillance cultures of the skin. The 
results of our study showed C. albicans to be not 
only a major colonizer of the skin and intravenous 
catheters in hematological inpatients, but also an 
agent of candidemia in this population. Along with 
other phenotyping and genotyping methods, the 
Odds and Abbott biotyping helps in differentiat-
ing particular types within the C. albicans species, 
permitting detection of the epidemiologic sources 
of nosocomial infections and routes of spread of 
this yeast.  
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